Back
Bumble Vs. Lyra Therapeutics Industry Stock Comparison
Buy
68
BMBL
Bumble
Last Price:
$6.50
Seasonality Move:
-24.64%
Buy
53
LYRA
Lyra Therapeutics
Last Price:
$13.62
Seasonality Move:
12.18%
Buy
53
Lyra Therapeutics (LYRA)
is a Buy
Is Lyra Therapeutics a Buy, Sell or Hold?
-
The current Lyra Therapeutics [LYRA] share price is $12.30. The Score for LYRA is 53, which is 6% above its historic median score of 50, and infers lower risk than normal.
-
LYRA is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
LYRA Stock Price Chart
What is Lyra Therapeutics's stock price today?
-
The Lyra Therapeutics share price today is $12.30Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYRA is experiencing slight selling pressure.
BMBL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.06 | Buy |
Relative Strength Index (14 RSI): | 71.73 | Buy |
Chaikin Money Flow: | 8199236 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.1 - 5.86) | Buy |
Bollinger Bands (100): | (4.1 - 6.74) | Buy |
LYRA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.7 | Buy |
Relative Strength Index (14 RSI): | 51.5 | Buy |
Chaikin Money Flow: | -18360 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.25 - 19.37) | Sell |
Bollinger Bands (100): | (4.05 - 13.13) | Buy |
BMBL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.34 | Buy |
20-day SMA: | 5.41 | Buy |
50-day SMA: | 5.14 | Buy |
200-day SMA: | 6.44 | Buy |
8-day EMA: | 5.49 | Buy |
20-day EMA: | 5.39 | Buy |
50-day EMA: | 5.32 | Buy |
200-day EMA: | 6.64 | Sell |
LYRA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 11.34 | Buy |
20-day SMA: | 14.23 | Sell |
50-day SMA: | 8.7 | Buy |
200-day SMA: | 9.89 | Buy |
8-day EMA: | 12.22 | Buy |
20-day EMA: | 12.24 | Buy |
50-day EMA: | 10.32 | Buy |
200-day EMA: | 22.55 | Sell |
Bumble Earnings Growth & BMBL Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.10 per share, a decrease next quarter of $0.13 per share, a decrease this year of $0.88 per share, and an increase next year of $0.05 per share.
Lyra Therapeutics Earnings Growth & LYRA Earnings Dates
-
Analysts estimate an earnings increase this quarter of $5.67 per share, a decrease next quarter of $0.00 per share, an increase this year of $42.75 per share, and an increase next year of $5.50 per share.
Bumble Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Lyra Therapeutics Technical Analysis
Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
11 | 12 | 13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |